ClinicalTrialsFinder

Carcinoma, Non-Small Cell Lung Clinical Trials in Seoul, Seoul-teukbyeolsi [seoul]

1 recruitingSeoul, Seoul-teukbyeolsi [seoul], South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-small Cell Lung CancerCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer714 enrolled315 locationsNCT06758401